the Image

Clinical Trial Details

If you are a patient or a caregiver and would like to learn more our cancer clinical trials call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials) or email cancerclinicaltrials@bsd.uchicago.edu .

Share this:
Brief Title Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma
Official Title A Phase II Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma
Principal Investigator Stadler, Walter
Brief Summary This research study is investigating a drug as a possible treatment for metastatic renal cell carcinoma. The intervention involved in this study is TAK-228.
Gender All
Ages 18 Years
Enrollment 40
Accepts Healthy Volunteers No
Lead Sponsor Dana-Farber Cancer InstituteOther
Collaborator Millennium Pharmaceuticals, Inc.Industry
Study Design
Study Phase Phase 2
Study Type Interventional
Contact Name David F McDermott, MD
Contact Phone 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials)
Condition Renal Cell Carcinoma
Detail for Health Professional (on clinicaltrials.gov)
More clinical trials by this PI